Sweegen, the global pioneer in wellness ingredient technologies and innovations, has just announced its victory against PureCircle in a Stevia Rebaudioside M (Reb M) patent lawsuit.
Steven Chen, CEO of Sweegen said, “Today’s judgment vindicates Sweegen and affirms the company’s position as an industry leader in innovative sweetener solutions.”
PureCircle, acquired by Ingredion in 2020, had filed the 2018 lawsuit against Sweegen in the US District Court for the Central District of California, accusing Sweegen of infringing 2 PureCircle patents covering the manufacture of Reb M.
The legal tide turned on PureCircle when Sweegen obtained a summary judgment that both of PureCircle’s asserted patents are invalid. Since it is impossible to infringe an invalid patent, the court’s invalidation of the asserted patents ends the infringement case against Sweegen at the US District Court.
“As a holder of core proprietary technologies of wellness ingredients, Sweegen vigorously guards its intellectual property rights and respects those of others,” added Chen. “We have always maintained that PureCircle’s patents were invalid and its case against Sweegen spurious.”
Sweegen is the primary producer of the highly sought-after non-GMO Reb M originating from the stevia leaf, made with a proprietary clean bioconversion method.
The case is PureCircle USA Inc., et al. v. Sweegen, Inc., et al., case number 8:18-CV-01679-JVS-JDE, in the US District Court, Central District of California, Southern Division.
Sweegen provides sweet taste solutions for food and beverage manufacturers around the world. It is on a mission to reduce the use of sugar and artificial sweeteners in global diet, and partners with its customers to create delicious zero-sugar products, using its its latest portfolio of sweeteners such as Bestevia® Rebs B, D, E, I, M, and N, and brazzein, together with its deep knowledge of flavor modulators and texturants.
For more information, click on:
Sweegen
